| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1738 | 2020 |
| B cells are associated with survival and immunotherapy response in sarcoma F Petitprez, A de Reyniès, EZ Keung, TWW Chen, CM Sun, J Calderaro, ... Nature 577 (7791), 556-560, 2020 | 1373 | 2020 |
| The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care EZ Keung, JE Gershenwald Expert review of anticancer therapy 18 (8), 775-784, 2018 | 425 | 2018 |
| Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities SA Tahir, J Gao, Y Miura, J Blando, RSS Tidwell, H Zhao, SK Subudhi, ... Proceedings of the National Academy of Sciences 116 (44), 22246-22251, 2019 | 166 | 2019 |
| Neoadjuvant relatlimab and nivolumab in resectable melanoma RN Amaria, M Postow, EM Burton, MT Tetzlaff, MI Ross, C Torres-Cabala, ... Nature 611 (7934), 155-160, 2022 | 162 | 2022 |
| Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab EZ Keung, M Burgess, R Salazar, ER Parra, J Rodrigues-Canales, ... Clinical Cancer Research 26 (6), 1258-1266, 2020 | 144 | 2020 |
| Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery EZ Keung, JL Hornick, MM Bertagnolli, EH Baldini, CP Raut Journal of the American College of Surgeons 218 (2), 206-217, 2014 | 132 | 2014 |
| Treatment at low‐volume hospitals is associated with reduced short‐term and long‐term outcomes for patients with retroperitoneal sarcoma EZ Keung, YJ Chiang, JN Cormier, KE Torres, KK Hunt, BW Feig, ... Cancer 124 (23), 4495-4503, 2018 | 120 | 2018 |
| Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020 JP Landry, KL Schertz, YJ Chiang, AD Bhalla, M Yi, EZ Keung, CP Scally, ... JAMA Network Open 4 (3), e210945-e210945, 2021 | 100 | 2021 |
| Immunocompromised status in patients with necrotizing soft-tissue infection EZ Keung, X Liu, A Nuzhad, C Adams, SW Ashley, R Askari JAMA surgery 148 (5), 419-426, 2013 | 92 | 2013 |
| Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma EZ Keung, YJ Chiang, RK Voss, JN Cormier, KE Torres, KK Hunt, ... European Journal of Surgical Oncology 44 (1), 170-177, 2018 | 90 | 2018 |
| Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS): Final results of SARC028 expansion cohorts. MA Burgess, V Bolejack, S Schuetze, BA Van Tine, S Attia, RF Riedel, ... Journal of Clinical Oncology 37 (15_suppl), 11015-11015, 2019 | 89 | 2019 |
| Systematic epigenomic analysis reveals chromatin states associated with melanoma progression P Fiziev, KC Akdemir, JP Miller, EZ Keung, NS Samant, S Sharma, ... Cell reports 19 (4), 875-889, 2017 | 89 | 2017 |
| Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma EZ Keung, AJ Lazar, KE Torres, WL Wang, JN Cormier, ... BMC cancer 18, 1-7, 2018 | 88 | 2018 |
| External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma A Iasonos, EZ Keung, O Zivanovic, R Mancari, M Peiretti, M Nucci, ... Cancer 119 (10), 1816-1822, 2013 | 77 | 2013 |
| BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis JO Schorge, MG Muto, SJ Lee, LW Huang, WR Welch, DA Bell, EZ Keung, ... Cancer Research 60 (5), 1361-1364, 2000 | 72 | 2000 |
| In-hospital and long-term outcomes after percutaneous endoscopic gastrostomy in patients with malignancy EZ Keung, X Liu, A Nuzhad, G Rabinowits, V Patel Journal of the American College of Surgeons 215 (6), 777-786, 2012 | 71 | 2012 |
| Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy CP Vellano, MG White, MC Andrews, M Chelvanambi, RG Witt, ... Nature 606 (7915), 797-803, 2022 | 68 | 2022 |
| Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy EZ Keung, PJ Nelson, C Conrad Stem Cells 31 (2), 227-235, 2013 | 67 | 2013 |
| Management of gastrointestinal stromal tumors EZ Keung, CP Raut Surgical Clinics 97 (2), 437-452, 2017 | 66 | 2017 |
